The economic slowdown has swelled the ranks of people without health insurance. But now it is also threatening millions of people who have insurance but find that the coverage is too limited or that they cannot afford their own share of medical costs.

Financial pain and physical pain may be linked: A new study says people who make less money and work in blue-collar jobs are more prone to be in pain.

Merck says it has received a warning letter from the Food and Drug Administration over concerns at one of its major vaccine manufacturing plants.

Two leading researchers warn that the entry of big companies like Microsoft and Google into the field of personal health records could drastically alter the practice of clinical research and raise new challenges to the privacy of patient records

Senator Hillary Rodham Clinton said in an interview on Wednesday that if elected president she would push for a universal health care plan that would limit what Americans pay for health insurance to no more than 10 percent of their income, a significant reduction for some families.

The U.S. Securities and Exchange Commission charged Canada's Biovail, two current senior executives and former Chief Executive Eugene Melnyk with engaging in a number of fraudulent accounting schemes, the agency said on Monday.

An estimated 10 million baby boomers -- or one out of eight -- will get Alzheimer's Disease according to a new report from the Alzheimer's Association.

Biotechnology company raised its 2008 earnings outlook and said it was on track to meet or exceed its key financial and product development goals through 2010.

Health insurer Humana slashed its first-quarter earnings forecast by nearly half Wednesday based on new projections for its Medicare plans for the elderly that provide prescription drug coverage.

A profit warning from WellPoint suggests that U.S. health insurers may not be a safe bet for investors to put their money in a troubled economy.

U.S. regulators have rejected a long-acting injectable form of Eli Lilly and Co's blockbuster schizophrenia drug Zyprexa, the company said Thursday, sending its shares down almost 2 percent.

As the democratic presidential candidates prepare to square off on health care issues at tonight's debate in Ohio, a new federal study points to accelerating growth in government spending on Medicare over the next ten years, as baby boomers become eligible for the healthcare entitlement program.

Genentech's shares soared as much as 11 percent on Monday after U.S. regulators approved its drug Avastin for the treatment of metastatic breast cancer.

Australian airline Virgin Blue Holdings missed profit estimates with a 8.8 percent fall in its first-half profit and flagged a tough environment in the second half, knocking down its shares more than 4 percent.